This provider's $16.2M in total Medicare payments ranks in the 94th percentile of Clinical Laboratory providers nationally.
Medicare payments to this provider grew 3790% from 2014 to 2023.
AI-generated analysis based on Medicare payment data.
Notable: Payments increased 78376% in 2021
Year-over-year payment surges can indicate changes in practice volume, new services, or billing pattern shifts.
Average per-service amounts submitted by the provider compared to what Medicare actually paid — the gap represents the markup.
| Year | Avg Submitted | Avg Paid | Markup Ratio | Gap per Service | Total Payments | Services | Beneficiaries |
|---|---|---|---|---|---|---|---|
| 2014 | $11.60 | $2.74 | 4.23x | $8.86 | $76.2K | 27.8K | 25 |
| 2015 | $8.20 | $1.96 | 4.18x | $6.24 | $50.3K | 25.7K | 18 |
| 2016 | $8.33 | $1.79 | 4.65x | $6.54 | $33.7K | 18.8K | 15 |
| 2017 | $32.00 | $5.21 | 6.14x | $26.79 | $38.4K | 7.4K | 22 |
| 2018 | $53.30 | $15.64 | 3.41x | $37.66 | $12.3K | 784 | 14 |
| 2021 | $440.48 | $404.02 | 1.09x | $36.46 | $9.6M | 23.8K | 29 |
| 2022 | $206.86 | $161.85 | 1.28x | $45.01 | $3.4M | 21.1K | 39 |
| 2023 | $231.04 | $183.38 | 1.26x | $47.66 | $3.0M | 16.2K | 45 |
| Code | Description | Services | Payments | Avg/Service | Markup |
|---|---|---|---|---|---|
| 81408 | Molecular pathology procedure level 9 | 1.9K | $3.9M | $2.0K | 1.02x |
| 81404 | Molecular pathology procedure level 5 | 4.8K | $1.3M | $274.82 | 1.11x |
| 81223 | Gene analysis (cystic fibrosis transmembrane conductance regular) full gene sequence | 1.9K | $920.3K | $494.00 | 1.04x |
| 81407 | Molecular pathology procedure level 8 | 790 | $668.6K | $846.27 | 1.07x |
| 81406 | Molecular pathology procedure level 7 | 2.4K | $664.8K | $282.88 | 1.12x |
| 81405 | Molecular pathology procedure level 6 genetic analysis | 2.1K | $628.3K | $301.34 | 1.11x |
| 81238 | Gene analysis (coagulation factor ix) full sequence analysis | 1.1K | $622.4K | $589.37 | 1.11x |
| G0483 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms | 2.5K | $601.3K | $243.16 | 1.24x |
| 81307 | Gene analysis (partner and localizer of brca2) full sequence analysis | 763 | $504.6K | $661.29 | 1.44x |
| 81317 | Gene analysis (postmeiotic segregation increased 2 [s cerevisiae]) full sequence analysis | 752 | $497.5K | $661.63 | 1.44x |
| 81439 | Test for detecting genes associated with inherited disease of heart muscle | 776 | $453.9K | $584.90 | 1.03x |
| 81249 | Gene analysis (glucose-6-phosphate dehydrogenase) full sequence analysis | 757 | $445.7K | $588.72 | 1.04x |
| 81298 | Gene analysis (muts homolog 6 [e coli]) full sequence analysis | 705 | $444.5K | $630.44 | 1.04x |
| 81226 | Gene analysis (cytochrome p450, family 2, subfamily d, polypeptide 6) common variants | 767 | $342.5K | $446.58 | 1.12x |
| 81286 | Gene analysis (frataxin) of full sequence | 1.1K | $306.5K | $273.67 | 1.07x |
| 81302 | Gene analysis (methyl cpg binding protein 2) full sequence analysis | 533 | $278.2K | $521.98 | 1.06x |
| 87798 | Detection test by nucleic acid for organism, amplified probe technique | 7.8K | $268.7K | $34.53 | 1.88x |
| 81401 | Molecular pathology procedure level 2 | 1.6K | $213.3K | $136.99 | 1.15x |
| 81403 | Molecular pathology procedure level 4 | 1.0K | $193.0K | $185.20 | 1.51x |
| 81400 | Molecular pathology procedure level 1 | 3.0K | $190.7K | $63.55 | 1.47x |
This provider submits charges 1.21 times higher than what Medicare actually pays.
A markup ratio of 1.21x means for every $100 Medicare pays, this provider initially charges $121. This is lower than the national average.
Always verify provider credentials and location before scheduling appointments. This data reflects Medicare payments and may not include all practice locations.
Other Clinical Laboratory providers in TX for peer comparison.
| Provider | Location | Total Payments | Status |
|---|---|---|---|
| Clinical Pathology Laboratories, Inc. | Austin, TX | $541.0M | ⚠️ Flagged |
| Quest Diagnostics Clinical Laboratories Inc | Irving, TX | $453.2M | ⚠️ Flagged |
| Laboratory Corporation Of America | Dallas, TX | $389.6M | ⚠️ Flagged |
| Quest Diagnostics Clinical Laboratories Inc | Houston, TX | $311.2M | ⚠️ Flagged |
| Laboratory Corporation Of America | Houston, TX | $299.4M | ⚠️ Flagged |
Share this provider's Medicare payment information
Last Updated: February 2026 (data through 2023, the latest CMS release)
Note: All data is from publicly available Medicare records. OpenMedicare is an independent journalism project not affiliated with CMS.
Believe this data is inaccurate? Dispute this data